International Journal of Cancer · 1992 · 16 citations · 29 references
MedicineOncologyPharmacologyRadiation DosimetryRadiation ProtectionRadiobiologyBiological Effects Of RadiationRadiation CarcinogenesisRadiation SensitivityRadiation TherapyRadiation ToxicityTotal Body IrradiationAdditive EffectsAdditive Effects ModelBiological ExposuresCancer Cell RadiosensitivityHistological Damage AssessmentIonizing Radiation CarcinogenesisRadiation-induced Lymphoid ToxicityTumor Radiosensitivity
Combined small doses of zinc aspartate and WR 2721 provided additive protection against radiation lethality in mice. Survival obtained with a small dose of WR 2721 which was ineffective alone could be enhanced to 83% by combining the drug with zinc aspartate, which on its own also displayed no effect. The survival of 25% provided by a higher dose of WR 2721 was increased significantly by adding zinc aspartate. Additivity was also tested in a model of radiation carcinogenesis. For this purpose, lethality and occurrence of lymphoid tumors induced by fractionated total-body irradiation were studied in C57B1/6 mice treated with zinc aspartate and WR 2721. In order to reveal additive effects, both agents were used at sub-optimal dosages. In mice subjected to 5 daily exposures of 1.9 Gy, the combination of zinc aspartate and WR 2721 was effective and enhanced the survival to 83% as compared with 25% afforded by WR 2721 alone (p < 0.005). Similarly, histological assessment of organ involvement with lymphoma revealed that zinc aspartate and WR 2721 alone did not bring about a significant reduction of lymphoma incidence. On the other hand, the combined agents diminished organ involvement with lymphoma to 9.1% as against 90% in the controls (p < 0.0005) and 62.5% with WR 2721 alone (p < 0.025). Thus, combined treatment with zinc aspartate and WR 2721 also inhibited radiation-induced lymphoid tumors.
29
The pharmacological basis of therapeutics
Arthur L. Frank · Environmental Research · 1981 · 2.7K citations
P R Twentyman, J. Martin Brown, Joe W. Gray et al. · JNCI Journal of the National Cancer Institute · 1980 · 379 citations
Medicine, Cancer Biology, Oncology +17
Henry S. Kaplan, Mary Bomberger Brown · JNCI Journal of the National Cancer Institute · 1952 · 232 citations